Regression of oesophageal carcinomas after neoadjuvant radiochemotherapy: Criteria of the histopathological evaluation

被引:44
作者
Baldus S.E. [1 ]
Mönig S.P. [2 ]
Schröder W. [2 ]
Metzger R. [2 ]
Lang S. [1 ]
Zirbes T.K. [1 ]
Thiele J. [1 ]
Müller R.P. [3 ]
Dienes H.P. [1 ]
Hölscher A.H. [2 ]
Schneider P.M. [2 ]
机构
[1] Institut für Pathologie, Universität zu Köln
[2] Klin. F. Viszeral- G., Universität zu Köln
[3] Klin. Poliklin. F. Strahlentherapie, Universität zu Köln
来源
Der Pathologe | 2004年 / 25卷 / 6期
关键词
Histopathology; Neoadjuvant radiochemotherapy; Oesophageal carcinoma; Regression grading; Therapy-induced tumor regression;
D O I
10.1007/s00292-004-0697-2
中图分类号
学科分类号
摘要
Following surgical resection locally advanced oesophageal carcinomas exhibit a bad prognosis and therefore neoadjuvant therapeutic strategies were developed. Because success of therapy is associated with the extent of tumor regression in this context, the introduction of objective histopathological criteria seems to be very important.This study included 67 patients with oesophageal carcinomas (cT2-cT4 cNx cM0) that were treated with a cisplatin- and 5-fluorouracil-containing simultaneous radiochemotherapy. In 43 patients squamous cell, in 24 cases adenocarcinomas were diagnosed. After completion of therapy, a surgical resection and a histopathological examination of the tissue specimens were performed. The extent of tumor regression was histologically evaluated and therapy-induced alterations were graded semiquantitatively. Thereby, a significantly favorable prognosis was observed in the group of patients that showed a regression of carcinomas of 90% or more. Additionally, the extent of a resorptive-histiocytic reaction, giant cells and lymphocytic infiltrates correlated with the grade of regression. These results underline the importance of an exact examination and histomorphological evaluation of the response for the assessment of survival probability after neoadjuvant radiochemotherapy of oesophageal carcinomas.
引用
收藏
页码:421 / 427
页数:6
相关论文
共 30 条
[1]  
Adelstein D.J., Rice T.W., Becker M., Et al., Use of concurrent chemotherapy, accelerated fractionation radiation, and surgery for patients with esophageal carcinoma, Cancer, 80, pp. 1011-1020, (1997)
[2]  
Becker K., Fumagalli U., Mueller J.D., Et al., Neo-adjuvant chemotherapy for patients with locally advanced gastric carcinoma: Effect on tumor cell microinvolvement of regional lymph nodes, Cancer, 85, pp. 1484-1489, (1999)
[3]  
Becker K., Mueller J., Fink U., Et al., Morphologische Responseevaluierung beim neoadjuvant chemotherapierten Magenkarzinom, Verh Dtsch Ges Pathol, 84, pp. 164-174, (2000)
[4]  
Bollschweiler E., Schroder W., Holscher A.H., Siewert J.R., Preoperative risk analysis in patients with adenocarcinoma or squamous cell carcinoma of the oesophagus, Br J Surg, 87, pp. 1106-1110, (2000)
[5]  
Darnton S.J., Allen S.M., Edwards C.W., Matthews H.R., Histopathological findings in oesophageal carcinoma with and without preoperative chemotherapy, J Clin Pathol, 46, pp. 51-55, (1993)
[6]  
Diez M., Ramos P., Medrano M.J., Et al., Preoperatively irradiated rectal carcinoma: Analysis of the histopathologic response and predictive value of proliferating cell nuclear antigen immunostaining, Oncology, 64, pp. 213-219, (2003)
[7]  
Dworak O., Keilholz L., Hoffmann A., Pathological features of rectal cancer after preoperative radiochemotherapy, Int J Colorectal Dis, 12, pp. 19-23, (1997)
[8]  
Esposito G., Pucciarelli S., Alaggio R., Et al., P27kip1 expression is associated with tumor response to preoperative chemoradiotherapy in rectal cancer, Ann Surg Oncol, 8, pp. 311-318, (2001)
[9]  
Hermann R.M., Krech R., Hartlapp J., Et al., Wertigkeit eines qualitativen Regressionsgradings als prognostischer Faktor für das Überleben bei präoperativ radiochemotherapierten Patienten mit fortgeschrittenen Kopf-Hals-Karzinomen, Strahlenther Onkol, 177, pp. 277-282, (2001)
[10]  
Japanese Classification of Gastric Cancer, 1st English Edn., (1995)